The systemic (subcutaneous) use described here is unproven and unapproved benefits seen with topical or in-vitro GHK-Cu should not be assumed to transfer to injection, and the safety of injected copper-peptide is not established
This specialized KLOW peptide blend combines four widely discussed peptide components into one formulation, offering researchers an opportunity to explore potential interactions between different peptide systems within controlled experimental environments
Synonyms include Cobalamin deficiency Vitamin B12 insufficiency Cyanocobalamin deficiency Lack of cobalamin B12 vitamin deficiency Insufficient Vitamin B12 levels Deficit of cobalamin Low B12 levels Inadequate Vitamin B12 Absence of cyanocobalamin Pantothenic acid deficiency Commonly asked questions
The only large study of healthy adults examining B12 supplement safety, using NHANES data, found no association between B12 supplementation and increased mortality at any dose, including 1,000 g/day or more (Wolffenbuttel, 2020)
If your vial is 30 mg/mL, 50 units delivers 15 mg, which is the maximum therapeutic dose and would be dangerous for anyone who has not spent months gradually titrating to that level
BPC-157 is more like a gut-protective, joints repair and inflammation-modulating peptide
